Kymera Therapeutics was listed on NASDAQ and disclosed insider stock sales via SEC filings.

The entities involved

• Kymera Therapeutics →

  biopharmaceutical company

  Nothing else this week.

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.Sep 22
• Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.Aug 19
• Kearny Financial stock is listed on Nasdaq, and an acquisition has been disclosed in documents filed with the SEC.Jun 18
• Burning Rock Biotech Limited listed its stock on the Nasdaq exchange and made insider trading filings with the SEC.Sep 1
• Insider trading disclosures for Synaptics were filed with the SEC, related to stock trades on NASDAQ.Jun 19